Mineralys Therapeutics MLYS
NASDAQ MLYS
$15.52 -0.29 (-1.83%)
At close: Nov 10, 2026 · 4:00 PM EST

Mineralys Therapeutics (MLYS) Interest Expenses (2026)

Updated

Analysis

Mineralys Therapeutics (MLYS) Interest Expenses (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn -
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 217.00 Mn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn -
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn -
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 462.00 Mn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn 435.00 Mn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 653.00 Mn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 269.00 Mn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn -
10 Mineralys Therapeutics 1.42 Bn -1.17 Bn - 3.19 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 3.19 Mn
API Access

Mineralys Therapeutics Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-expenses&ticker=MLYS&period=max&api_key=YOUR_API_KEY